Study S003420

A Phase IIB/III Multicenter Randomized Trial to Evaluate the Combination of Low-Dose Cyclosporine and Omeprazole Versus Omeprazole Alone in Participants With New Onset Type 1 Diabetes.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01762644
Acronym: IIT
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: WITHDRAWN
Enrollment: 0
Start: 2015-08
Primary completion: 2016-05
Lead sponsor: Perle Bioscience, Inc.
Conditions: Type 1 Diabetes
Interventions: DRUG:Oral Cyclosporine and Oral Omeprazole; DRUG:Oral Omeprazole
Results posted: FALSE
Secondary identifiers: EUDRACT_NUMBER:2015-000105-39; NIH:2015

Registered primary outcomes

Insulin Independence and Hemoglobin A1c (A1C) < 6.5% [24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.